\
&
Contact us
Published on | 1 year ago
Programmes HealthThe European Partnership on Rare Diseases (ERDERA) has opened its first Joint Transnational Call for Proposals on 'Pre-clinical therapy studies for rare diseases using small molecules and biologicals – development and validation'. The timeline of the call is as follows:
Research Foundation Flanders (FWO) participates in this call. More information on available funding for researchers based in Flanders and on who can apply & how is specified in the call documents. Questions? Please contact europe@fwo.be .
Projects should address at least two of the following:
Please note, certain approaches, including ATMP therapies and clinical trials, are excluded from this call. Detailed eligibility criteria are outlined in the Call Guidelines.
More information is available on the ERDERA website.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
AI Continent Deployment: Best use of technologies
The European Commission has published the recording and presentations from its 18 December 2025 info session on the call topics Data Space for Manufacturing (DIGITAL-2026-DSM-AI-09-DS-MANUFACTUR-STEP) and European Digital Media Observatory hubs (DIGITAL-2026-BESTUSE-TECH-EDMO-09-HUBS). The slides and recording are available on ... read more
Textgain is a Flemish SME and a partner in Digital Europe project BENEDMO, which answered to call ‘European Digital Media observatory (EDMO) - National and multinational hubs’.
Its task within the project is to further develop technologies to effectively detect sources of polarisation and disinformation, allowing journalists and moderators to quickly mitigate the harmful effects of such messages.